A comprehensive study on malignant tumours of the maxillary sinus. by Venktesh, V
  
A COMPREHENSIVE STUDY ON MALIGNANT 
TUMOURS OF THE MAXILLARY SINUS 
 
 
 
 
Submitted in partial fulfillment of the requirements for  
 
M.S.Degree Examination- Branch IV 
OTO-RHINO LARYNGOLOGY 
UPGRADED INSTITUTE OF OTO-RHINO LARYNGOLOGY 
MADRAS MEDICAL COLLEGE 
CHENNAI - 600 003. 













THE TAMIL NADU 
DR.M.G.R.MEDICAL UNIVERSITY 
CHENNAI, TAMIL NADU 
 
SEPTEMBER - 2006 
 
CERTIFICATE 
 
       This is to certify that the dissertation titled                                           
"A COMPREHENSIVE STUDY ON MALIGNANT TUMOURS OF 
THE MAXILLARY SINUS" is a bonafide work done by 
Dr.VENKTESH. V, in partial fulfillment of the requirements for MS 
(ENT) Branch IV Examination of The Tamilnadu Dr.M.G.R.Medical 
University to be held in September 2006.  
 
 
 
 
Prof.Dr.Kalavathy Ponniraivan, B.Sc., M.D., 
Dean,     
Madras Medical College &, 
Government General Hospital 
Chennai-600 003 
 
Prof.S.Amma Muthu, M.S., D.L.O., 
Director & Professor 
Upgraded Institute of Oto-Rhino laryngology, 
Institute of Speech & Hearing 
Madras Medical College, 
Govt. General Hospital 
Chennai - 600 003 
 
    
 
 ACKNOWLEDGEMENT 
I sincerely thank my beloved Director and Professor of the institute of 
Oto-Rhino-laryngology, Madras Medical College, Prof.S.Amma Muthu, 
M.S., D.L.O., for his encouragement, motivation and guidance from the 
beginning to the completion of this dissertation. 
 I thank our Dean Dr.Kalavathy Ponniarivan, B.Sc., M.D., for 
permitting me to do this study. 
 I profoundly thank Prof.Dr.U.Venkatesan, M.S., D.L.O. Additional 
Professor of ENT, Prof.Dr.A.K.Sukumaran, M.S., D.L.O., Additional 
Professor of ENT, Prof.Dr.A.P.Sambandan, M.S., D.L.O., of the 
Upgraded Institute of Oto-Rhino-laryngology, Madras Medical College, 
Chennai. 
 It is my pleasure to record my sincere and profound gratitude to all 
the Assistant Professors of UIORL, who had undertaken willingly all the 
demands placed on them. 
 I also wish to thank all my fellow Post Graduate Students for their 
invaluable help rendered during this study. 
 I wish to thank all the paramedical staff of UIORL for their 
invaluable help. 
 Last but not the least I wish to thank the Living Books, the patients 
without whom this study would not have found its present form. 
  
CONTENTS 
 
 
 
 
S.No.  Page No. 
1. Introduction 01 
2. Aims of Study 02 
3. Surgical Anatomy of Maxilla 03 
4. Classification of Nasal And Paranasal Sinus 
Tumours 
 
08 
5. Staging of Maxillary Sinus Carcinoma 11 
6. Review of Literature  16 
7. Materials and Methods 24 
8. Proforma 54 
9. Observation  32 
10. Discussion 47 
11. Conclusion 53 
12. Bibliography  
13. Master Chart  
 
  
 
 
INTRODUCTION  
 
 
 
 Malignant tumours of the maxillary sinus usually presents at an 
advanced stage due to the surrounding bony walls of maxilla. So by the 
time the patients reaches an oto-rhino-laryngologist, the condition is 
advanced making treatment difficult. 
 
 The malignant tumours of maxillary sinus occurs in only one in 
2,00,000 persons per year. 
 
 This emphasizes the importance of clinical features, in detecting 
the disease at an earlier stage and improve the prognosis of the patients. 
Hence this study was conducted to evaluate the importance of symptoms 
and signs in facilitating early diagnosis and in predicting the appropriate 
extent of disease. 
  
  
 
 
 
 
AIMS OF STUDY 
 
  
In malignant tumours of the maxillary sinus, 
1. To study the age and sex incidence of the tumours. 
2. To find the incidence of different symptoms  
3. To correlate the clinical findings and stage of the disease  
4. To compare the clinical staging and radiological staging with per-
operative involvement 
5. To determine the prognostic factors in malignant tumours of 
maxilla particularly in relation with staging of the lesion. 
 SURGICAL ANATOMY OF MAXILLA 
 
The maxilla is the second largest of facial bones maintaining the 
facial contour, forming roof of the mouth, lateral wall and floor of nasal 
cavity, anterior surface of infratemporal fossa and pterygopalatine fossa 
and the floor of the orbit. The body of maxilla is a quadrilateral pyramid. 
it contains the maxillary sinus. 
 
It has four surfaces and four processes. 
 
 
Surfaces 
 
1. Anterolateral (Anterior surface, Facial surface) 
2. Posterol ateral (Posterior surface, Infratemporal surface) 
3. Medial surface (Nasal surface) 
4. Superior surface (Orbital surface). 
Processes 
1. Zygomatic process 
2. Alveolar process 
3. Frontal process 
4. Palatine process. 
It articulates with maxilla of opposite side, nasal bone, maxillary 
process of fiontal bone, maxillary process of zygoma, horizontal and 
 pyramidal process of palatine bone, pterygoid plates of sphenoid bone, 
ethmoid bone and inferior nasal concha. 
Maxillary sinus 
It is the largest of the paranasal sinuses and is contained within the 
body of each maxilla. It is pyramidal in shape with its apex directed 
laterally and base lies medially. 
 
Relations 
Anterior wall : Related to the cheek 
Posterior wall : Separates the sinus from infratemporal & 
pterygopalatine fossa 
Medial wall  : Separates the sinus from the nasal cavity. 
Contains the ostium. 
Roof   : Separates the sinus from the orbital  
cavity and is traversed by infraorbital 
nerve and vessels. 
Floor   : Related to alveolar processes carrying the 
molar teeth and palatine process of 
maxilla. 
 
The floor of the sinus lies at a level 1.0 - 1.2 cm below that of the 
floor ol the nasal cavity in adults. In child floor of the sinus is at a higher 
 level and at 12 years the floor of sinus is at the level of the floor of nasal 
cavity. The average dimensions in the adult skull are 33 mm in height, 23 
mm in width and 34 mm anteroposteriorly. The approximate volume is 
14.75 ml but a large antrum may hold upto 30 ml. 
 
It opens into the ethmoidal infundibulum in the middle meatus of 
the nasal cavity. It is 3-4 mm in diameter. The ostium is very large, but is 
made small by the following bones which articulate here. Ethmoid from 
above, lacrimal from in front, perpendicular plate of the palatine from 
behind and Inferior nasal concha from below. Accessory ostia are present 
in about 30% of specimens. 
 
Embryology 
 
The maxillary process grows ventrally from the dorsal end of the 
mandibular process to join lateral nasal process. The maxilla arises during 
6th or 7th weeks from five ossification centers. The maxillary sinus is the 
first to appear (7 - 10 weeks) as a shallow groove expanding from 
primitive ethmoidal infundibulum into the mass of the maxilla. 
 
Blood supply 
 
Through small arteries that pierce the bony walls originating from 
the maxillary, facial, infraorbital and greater palatine arteries. 
  
Veins accompany the arteries and drain into anterior facial vein and 
the pterygoid plexus. 
 
Lymphatic drainage 
 
It is relatively poor, but drains into retropharyngeal nodes and from 
there to the upper deep cervical nodes. 
Nerve supply 
 
The sinus is innervated by the superior alveolar nerves (anterior, 
middle, posterior), anterior palatine nerve, and the infraorbital nerve. 
 
Histology 
 
The sinus is lined by ciliated columnar epithelium which contains 
the highest density of goblet cells compared to other sinuses. 
 
INFRATEMPORAL FOSSA 
 
Boundaries 
Roof : Infratemporal surface of greater wing of  
sphenoid and by a small part of squamous 
temporal bone. 
Inferior : Continuous with the parapharyngeal space 
 Anterior : Posterior wall of maxilla 
Posterior : Styloid apparatus, carotid sheath and  
prevertebral fascia 
Medial : Lateral pterygoid plate 
Lateral : Medial surface of ramus of mandible,  
zygomatic arch, masseter and temporalis 
muscles and upper most part of the deep lobe of 
parotid. 
 
Contents 
 
1. Lateral and medial pterygoid muscles 
2. Mandibular nerve and its branches 
3. Maxillary artery and vein 
4. Pterygoid plexus of vein within lateral pterygoid muscle 
5. Chorda tympani branch of facial nerve. 
 CLASSIFICATION OF NASAL AND PARANASAL 
SINUS TUMOURS 
 
Benign Malignant 
A) Epithelial 
1. Adenoma 
2. Papilloma 
 
1. Squamous cell carcinoma 
2. Adeno carcinoma 
3. Anaplastic carcinoma 
4. Transitional cell carcinoma 
5. Malignant melanoma 
6. Salivary gland tumours 
    a) Adenoid cystic carcinoma     
    b)Mucoepidermoid carcinoma 
    c) Malignant pleomorphic adenoma 
7. Aesthesioneuroblastoma 
B) Non - Epithelial  
1. Fibroma 
2. Hemangioma 
3. Nasal glioma 
4. Neurilemmoma 
5. Chondroma 
1. Fibrosarcoma 
2. Angiosarcorna 
3. Hemangiopericytoma 
4. Malignant lymphoma 
5. Rhabdomyos arcoma 
 
  
6. Osteoma 
7.        Meningioma 
6. Lymphosarcoma 
7. Plasmacytoma 
8. Burkitts lymphoma 
FIBRO - OSSEOUS TUMOURS 
Benign 
Osteoma 
Ossifying fibroma 
Osteoblastoma 
Osteoid osteoma 
Chondroma 
Chondroblastoma 
Chondromyxoid fibroma 
Desmoplastic fibroma 
Malignant 
Osteosarcoma 
Ewing’s sarcoma 
 
 
Chondrosarcoma 
 
Fibrosarcoma 
Malignant fibrous histiocytoma 
ODONTOGENIC TUMOURS 
Epithelial 
1. Ameloblastoma 
2. Adenomatoid odontogenic tumour 
3. Calcifying epithelial odontogenic tumour 
4. Ameloblastic fibroma 
5. Ameloblastic fibrosarcorna 
6. Odontoma 
 
 
  
 
Mesodermal 
1. Myxoma 
2. Odontogenic fibroma 
3. Cementoma 
a) Benign cementoblastoma 
b) Cementifying fibroma 
c) Cemento ossifying fibroma 
d) Familial gigantiform cementomas 
METASTATIC TUMOURS 
MISCELLANEOUS TUMOURS 
1. Melanotic neuro - ectodermal tumour 
 STAGING OF MAXILLARY SINUS CARCINOMA 
 
1. Sebileau classification (1906) 
Draw two parallel lines  1. Through floors of the orbits 
2. Through floors of the maxillary antrum 
Divides into 
1. Supra structure : Ethmoid, sphenoid, frontal sinus and 
olfactory portion of nose 
2. Mesostructure : Maxillary sinus and respiratory 
portion of nose. 
3. Infrastructure : Alveolar process 
 
2. Ohngren’s classification (1933) 
 
One line passing from inner canthus of the eye to the angle of the 
mandible and another line passing through mid pupillary region. 
 
It divides maxillary sinus into four quadrants. 
 
1. Antero inferior medial 
2. Antero inferior lateral 
3. Postero superior medial 
4. Postero superior lateral 
 3. Modified Sisson classification (1963) 
       T1 : Invasion of anterior wall (or) 
Inferior nasoantral wall (or) 
Anterior medial wall 
 
T2 : Invasion of lateral wall without muscle involvement 
Invasion of superior wall without orbital involvement 
T3 : Invasion of pterygoids (or) orbit (or) anterior ethmoid cells 
(or) anterior wall without involvement of cheek. 
T4 : Invasion of cribriform plate (or) pterygomaxillary fossa 
(or) nasal fossa (or) other sinuses (or) pterygoid plate 
erosion. 
 
4. Lederman classification (1969) 
Two horizontal lines - one passing through floor of orbits. Other 
passing through floor, of maxillary sinuses. 
Two vertical lines passing through medial orbital walls. 
T1 : Tumours limited to one sinus (or) tissue of origin 
T2 : Spread limited horizontally to same region (or) two 
adjacent but vertically related regions. 
 
No skin 
involvement 
 T3 : 1. Tumour involving three regions with orbital 
involvement. 
2. Tumour extending beyond the upper jaw with 
invasion into nasopharynx, cranium, pterygopalatine 
fossa (or) oral cavity. 
 
5. Harrison classification (1978) 
T1 : Limited to antral mucosa without evidence of erosion of 
bone. 
T2 : Bone erosion but without involvement of the facial skin, 
orbit, ethmoid (or) pterygopalatine fossa. 
T3 : Involvement of orbit, ethmoids (or) facial skin. 
T4 : Tumour extension to the nasopharynx, sphenoid sinus, 
cribriform plate (or) pterygopalatine fossa. 
 
6. American Joint Committee on Cancer (AJCC) Classification 
(1988) Primary tumour (T) 
Tx : Minimum requirements to asses the primary tumour 
cannot be met. 
T0 : No evidence of primary tumour 
Tis : Carcinoma in situ 
 
 T1 : Tumours confined to the antral mucosa of the 
infrastructure with no bone erosion or destruction 
T2 : Tumour confined to the suprastructure mucosa without 
bone destruction, or to the infrastructure with 
destruction of medial (or) inferior bony walls only. 
T3 : More extensive tumour invading skin of cheek, orbit, 
anterior ethmoid sinus, (or) pterygoid muscles. 
T4 : Massive tumour with invasion of cribriform plate, 
posterior ethmoids, sphenoid, nasopharynx, pterygoid 
plates, base of skull (or) cranial nerves. 
 
7. International Union for Cancer Control (UICC – 2002) 
 
T1 : Tumour limited to the maxillary sinus mucosa with no 
erosion or destruction of bone 
T2 : Tumour causing bone erosion or destruction Including 
extension into the hard palate and/or middle nasal 
meatus, except extension to posterior wall of maxillary 
sinus, subcutaneous tissues, floor or medial wall of 
orbit, pterygoid fossa, ethmoid sinuses 
 
 
 T3 : Tumour invades any of the following: Bone of the 
posterior wall of maxillary sinus, subcutaneous tissues, 
floor or medial wall of orbit, pterygoid fossa ethmoid 
sinuses 
T4a : Tumour invades anterior orbital contents, skin of cheek, 
pterygoid plates infratemporal fossa, cribriform plate, 
sphenoid or frontal sinuses 
T4b : Tumour invades any of the following: Orbital apex, 
dura, brain, middle cranial fossa, cranial nerves other 
than maxillary division of trigeminal nerve V 
nasopharynx or clivus 
 
 REVIEW OF LITERATURE 
Syme et al, reported in 1828, a successful performance of total 
maxillectomy with orbital exenteration. 
In 1906, Sebileau, described a classification for maxillary sinus 
neoplasms. 
Ohngren et al in 1933, divided the facial skeleton as seen in 
profile from inner canthus of the eye to the angle of mandible creating 
posterosuperior and anteroinferior sectors. 
In 1943, Windeyer described deep x-ray exposure followed in 4 
weeks by removal of the palate and alveolus. 
In the same year, Lederman used palatal fenestration with 
intracavitary radium therapy. 
In 1952, as advances in surgical techniques, anaesthesia, blood 
replacement and antibiotics reduced, the mortality rate of radical 
maxillectomy, the trend switched to radical surgery combined with 
radiation. 
Sisson and colleagues in 1963, developed a TNM system for 
classification of antral carcinomas. 
 Harrison in 1978 developed a staging system based on presence of 
bony erosion with subsequent spread. 
 
Parsons C et al in 1979 reviewed 32 patients with histologically 
proven malignancy of maxilla and studied the CT scans. The radiological 
features of tumour were sinus opacification, a soft- tissue mass, bone 
erosion and/or displacement, sclerosis, and new- bone formation. 
Measurements of tissue densities were not helpful in distinguishing 
tumour from benign disease. Significantly greater tumour extent was 
demonstrated by CT than by conventional methods in 15 patients; the 
additional tumour most commonly involved the pterygoid region or orbit. 
 
Som PM in 1981 showed that although bowing of the posterior 
antral wall occurs most commonly with juvenile angiofibroma, it can 
occur with any slow growing noninvasive lesion involving the 
retromaxillary region. Cases of schwannomas, a lymphoepithelioma, and 
a fibrous histiocytoma are presented as examples of the nonspecificity of 
the antral bowing sign. 
 
In 1984, Weber AL, and Stanton AC showed that malignant 
tumours of the paranasal sinuses are often found to be greatly advanced 
by the time a clinical or radiologic diagnosis is established. Therefore, the 
 overall cure rate is low, even when surgery and radiation therapy are 
combined. The clinical manifestations and pathologic findings are 
analyzed in 200 cases to illustrate the wide spectrum of these tumours as 
to their type, specific location, and the extent to which they can spread 
within the sinuses and to adjacent anatomic areas. 
 
Johnson et al in 1984, reviewed 79 patients with sinus and 
paranasal sinus tumours. Forty -seven of 79 patients with sinus and 
paranasal sinus had clinical, radiographic or operative evidence of orbital 
involvement. Seventy percent of those patients with orbital extension had 
clinical or radiographic involvement of the orbit at the time of initial 
presentation. The most common tumour seen was squamous cell 
carcinoma. The maxillary sinus was the most frequent site of origin. A 
diagnosis of sinusitis is tentative and should be reevaluated early with 
repeat roentgenographic studies and biopsy, especially in the presence of 
protracted facial and eye pain. When ordering CT scans, one must 
specifically request cuts of the base of the sinuses and skull as routine 
brain CT scans do not evaluate those regions. 
 
Larheim et al in 1984, made comparison between the frequency of 
alveolar bone-palate destruction caused by carcinomas originating in the 
maxillary sinus (31 patients), palate (15) and maxillary gingiva (9). 
Radiographic examination included conventional sinus projections, 
 supplemented with hypocycloid tomography (47), computed tomography 
(28) and orthopantomography (11). Almost every second tumour 
presenting with alveolar bone involvement appeared to be a maxillary 
sinus cancer. Gingival and palatal cancers also caused frequent bone 
destruction. Radiographic examination, including tomography, was of 
great value in demonstrating the extent of these tumours. Three cases 
clinically diagnosed as gingival cancers proved to originate in the 
maxillary sinus. 
 
In 1986, Kondo M, Ando Y did a study on maxillary squamous cell 
carcinomas staged by CT scans. In 72 patients with maxillary squamous 
cell carcinoma, computed tomography (CT) alone was used for T-staging 
according to the AJC classification. Five, 31, and 36 tumours were 
diagnosed as T2, T3, T4, respectively. Addition of maxillectomy to 
treatment seemed to have improved the local prognosis in T3 and T4 
tumours. High radiation doses of 60 Gy or more seemed to be beneficial 
for patients with T3 tumours and without maxillectomy. CT will be of 
great help in classifying tumours objectively. But more importantly, it 
will reveal respectability and dictate treatment of choice by delineating 
the tumour extent precisely. 
 
Graber HR et al, in 1986, illustrated the CT appearances of 
malignant tumours of paranasal sinus on the basis of 15 patients and 
 discussed the differential diagnoses. Malignant soft tissue tumours in the 
paranasal sinuses are characterised on CT by their non homogeneous 
structure; they may destroy the bony margins of the sinus and infiltrate 
neighbouring regions in certain preferred directions, and they may 
enhance following the administration of contrast. Precise definition of the 
malignant tumour by CT permits their exact staging, may help to 
determine therapy and is valuable for serial observation. It remains to be 
seen, however, whether the improved radiological diagnosis results in 
improved prognosis of malignant tumours of the paranasal sinuses. 
 
In 1991, Ben Achour, et al, reported about a retrospective study on 
52 cases of malignant tumours of the maxillary sinus gathered from 
January 1, 1977 to December 31, 1985 in the Department of 
Cervicofacial and ENT Carcinological Surgery of the Salah Azaiz 
Institute in Tunis. Epidermoid carcinomas dominate, but the histological 
types encountered are quite various; the tumours are very advanced on 
the first consultation in most cases. Computed tomography was a great 
help to assess extension prior to treatment and during follow-up. The 
evolution involved frequent recurrence and a great number of deaths 
during the first year. 
 
Pera Ramon E et al in 1991, described 2 cases of adenocarcinoma 
of nasal cavities and paranasal sinuses. Adenocarcinomas are most often 
 seen in the middle turbinate and ethmoid sinus. He reported 2 cases and 
discussed its clinical findings, the treatment and possible etiologies. 
 
Shibuya H in 1991 discussed CT features of second cancers of the 
maxillary sinus. Five patients with a second maxillary cancer (squamous 
cell carcinoma), which developed 6 to 17 years after initial treatment for 
the first cancer on the opposite side, were compared with 21 control cases 
with a primary cancer on the basis of computed tomography (CT) 
findings. Generally, the second cancer was found at an earlier stage. The 
specific CT findings of early sinus carcinoma were uneven soft tissue 
distribution in the antrum and tumour permeation with bone fragments 
remaining at the original tumour site. These findings may be helpful for 
distinguishing this cancer from benign chronic sinusitis and/or other 
malignant sinus disease. The pterygoid process, medial bony wall, and 
ethmoid sinus had a tendency to be spared in most of the 5 patients with 
second maxillary cancer compared to the 21 control cases. 
 
Sakaguchi M, Moriya K et al, in 1993, reported a 68-year-old 
male with a rare case of synchronous bilateral carcinomas of the 
maxillary sinus. A CT scan revealed a large tumour mass that extruded 
from the left maxillary sinus; tissue of soft density filled the right antrum 
which had intact bony walls. A probe antrostomy on the right side 
disclosed a tumour which was diagnosed histologically as the same 
 poorly differentiated squamous cell carcinoma as that in the left antrum. 
The incidence and aetiology of this disorder are presented, and its 
diagnosis and management are discussed. 
 
In 1993, Ichimura et al evaluated Trismus in patients with 
malignant tumours in the head and neck. 21 patients manifesting trismus 
out of 212 patients with malignant tumours in the head and neck (treated 
in Tokyo University Branch Hospital from 1983 to 1991) were reviewed. 
Nine patients developed trismus either by infiltration of the muscles of 
mastication or by reflex spasm. Trismus was considered to have 
developed as a result of irradiation in five cases and of surgical 
intervention in seven cases. Maxillary sinus tumours were often without 
trismus even when they extended posteriorly to the infratemporal fossa. 
 
Wang P et al in 1997 discussed the CT examination and diagnosis 
of oral and maxillofacial tumour invading pterygopalatine fossa. CT 
findings in 33 cases (proven histopathologically) suffered from oral and 
maxillofacial tumours affecting the pterygopalatine space were 
retrospectively analyzed. The authors conclude that the main CT 
manifestations of this space involvement by tumours can be depicted as a 
soft tissue mass occupancy and the wall structures destruction. Tumours 
occurring in different locations of oral and maxillofacial areas have 
 different features of CT appearances. As a modality of imaging, CT has 
an important role for assessing the lesions of this fossa. 
 
Ram B, Saleh HA in 1998, described rare case of verrucous 
carcinoma of maxillary antrum. Verrucous carcinoma is a distinct variant 
of well differentiated squamous cell carcinoma. Its occurrence in the 
maxillary antrum is rare. Only three cases have previously been 
documented. We present a case report of verrucous carcinoma in the 
maxillary antrum and a review of the literature. 
 MATERIALS AND METHODS 
 The study was done in Upgraded Institute of Otorhinolaryngology, 
Government General Hospital, Chennai from July 2003 to Dec 2004. 
 Out of the patients who attended the outpatient department during 
the period, those with symptoms and signs suggestive of malignant 
tumour of maxillary sinus were screened further. 
 After thorough clinical examination, the patients were subjected to 
diagnostic nasal endoscopy and CT scan of the paranasal sinus. 
 A diagnostic nasal endoscopy and biopsy was done. Those with 
histologically confirmed malignancy were selected for the study. 
 The total number of 20 patients were selected for the study and 
their peroperative findings were noted. 
 Depending on the clinical assessment of the extent of the tumour 
and the condition of patient, treatment was planned and executed. 
Curative treatment consisted of surgery followed by radiotherapy. 
 The surgeries performed were total maxillectomy, total 
maxillectomy with orbital exenteration. 
  Patient were advised to report for a followup regularly at intervals 
of monthly duration of first 6 months and once in 3 months of the next 1 
year. 
  
The symptoms of the patients were categorized into five groups. 
Group I : Oral symptoms like dental pain in premolars and molars, 
malocclusion, loosening of tooth, trismus, oro-antral 
fistula’s ulceration of the palate (or) alveolar ridge and ill 
fitting denture 
Group II : Nasal symptoms like unilateral nasal obstruction, 
unilateral nasal discharge and chronic epistaxis 
Group III : Ocular symptoms like exopthalmos, diplopia, impairment 
of vision and epiphora 
Group IV : Facial symptoms like cheek swelling numbness (or) 
paraesthesia of cheek skin, skin ulceration, widening of 
nasal dorsum and widening of intercanthal distance. 
Group V Neurological symptoms not found in other groups like 
headache, unilateral anosmia, pain and numbness over the 
face due to involvement of entire maxillary division of V 
nerve and rare occurrence of VII and VIII palsy   
     
  The clinical examination and findings were done in the following 
order uniformly : 
1) Examination of nasal cavity and noting of any intranasal mass (or) 
medial displacement of lateral nasal well. 
2) Examination of oral cavity, which includes, inspection and 
palpation of hard palate, maxillary teeth, alveolar and 
gingivobuccal sulcus. 
3) Visualization of nasopharynx and choana 
4) Examination of the cheek for the presence of mass, inflammation 
(or) involvement of infraorbital nerve. 
5) Assessment of visual acuity, extra – ocular movements and 
displacement of the globe. 
6) Examination of the ear for otitis media with effusion 
7) Performing a cranial nerve examination 
8) Examination of neck for regional lymph nodes. 
Imaging 
 CT scan paranasal sinuses were done in all 20 patients (coronal and 
axial view, plain and contrast) 
  Attenuation values in the range of 30 – 90 HU were considered 
positive for growth and their extent noted. 
 Involvement of antral mucosa, alveolar, hard palate, orbital floor, 
lamina papyraceae, orbital apex, nasal cavity, anterior and posterior 
ethmoidal cell; nasopharynx, sphenoid, cribriform plate, upper deep 
cervical submandibular lymphnodes, pterygoid plates and infratemporal 
fossa were noted. 
 During surgery, the exact extent of tumour involvement noted. 
 PROFORMA  
Name  :    Age :  Sex :  IP.No : 
Occupation  :    Socioeconomic Status 
      - Low / Middle / High 
Address : 
Symptoms :    Yes  No 
 Oral Symptoms 
 Nasal Obstruction 
Epistaxis 
Others 
 Orbital symptoms 
 Cheek swelling 
Anaesthesia / Paraesthesia 
Ulcer 
  Neurological symptoms 
Signs      Yes   No   
 Hard palate  
Maxillary tooth loosening 
Alveolar 
Gingivobuccal sulcus 
Mouth opening 
       Yes   No 
 Nasal Mass 
Choana 
Nasopharyngeal extension 
Otitis media with effusion 
 Displacement of globe 
Restriction of extraocular movements 
Change in Visual Acquity 
 Mass in the Check 
Anaesthesia / Paraesthesia 
Ulceration of Skin 
Peau de orange 
 Involvement of 
Maxillary N 
VII  N 
VIII N 
 Lymphnode 
Upper Deep cervical 
Submandibular  
 RADIOLOGICAL FINDINGS 
Involvement of       Yes  No 
 Antral mucosa 
 Alveolar 
Hard palate 
 Orbital floor 
Lamina Papyraceae 
Orbital Apex 
 Middle Meatus 
Anterior ethmoidal cells 
Posterior ethmoidal cell 
Nasopharynx 
Sphenoid 
Cribriform plate 
 Nerve involvement 
 Lymph node 
- Upper deep cervical 
- Submandibular 
 Pterygoid plate 
Diagnosis : 
 
Operative Procedure : 
 PER – OPERATIVE FINDINGS 
Involvement of      Yes  No 
 Antral mucosa 
 Alveolus 
 Hard palate 
 Orbital floor 
Lamina papyraceae 
Orbital Apex 
Orbital Periosteum 
 Skin of cheek 
 Middle meatus 
Anterior ethmoidal cells 
Posterior ethmoidal cells 
Nasopharynx 
Sphenoid 
Cribriform plate 
 Nerve involvement 
 Pterygoid muscle 
Pterygoid plate 
Intratemporal fossa 
Skull base 
 
 
  
 
 
 
 
 
CT SCAN PARANASAL SINUS 
 
INVOLVEMENT OF THE TUMOUR IN THE NASAL CAVITY 
AND MAXILLARY SINUS WITH EROSION OF THE 
PTERYGOID PLATE 
 
 
 
  
 
 
 
 
 
CT SCAN PARANASAL SINUS 
 
INVOLVEMENT OF THE TUMOUR IN THE NASAL CAVITY 
AND MAXILLARY SINUS WITH EROSION OF THE 
POSTEROLATERAL WALL WITH EXTENSION INTO THE 
ANTERIOR ETHMOID AIR CELLS. 
 
 
 
  
 
 
 
 
 
 
POST OPERATIVE PICTURE 
 
 
 
 
 
 
 
 
 
 
 OBSERVATION 
 
AGE INCIDENCE 
 
 The maximum age of the patient in the study was 65 years and 
minimum was 29 years. 
 
Age in 
years 
No. of 
Patients 
Percentage 
1 – 10 0 0 
11 – 20 0 0 
21 – 30 1 5% 
31 – 40 3 15% 
41 – 50 5 25% 
51 – 60 8 40% 
61 – 70 3 15% 
   
 Patients belonging to fifth and sixth decade of life had the 
maximum incidence (i.e.) 65%. 
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SEX INCIDENCE 
 
  
Sex No. of Patients Percentage 
Male 14 70% 
Female 6 30% 
 
 
 Around 3/4th of our patients were males 
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DURATION OF COMPLAINTS 
 
Duration No. of cases Percentage 
1 – 29 days 0 0 
1 – 3 months 4 20% 
4 – 6 months 11 55% 
7 – 12 months 4 20% 
1 – 1 ½ years 1 5% 
1 ½ - 2 years 0 0 
 
Most of the patients presented to our OP department at 4 to 6 
months duration. i.e., 55%.   
 
  
 
 
INCIDENCE OF DIFFERENT SYMPTOMS 
  
Symptoms No. of cases Percentage 
Oral 12 60% 
Epistaxis 15 75% 
Nasal Obstruction 13 65% 
Cheek swelling 10 50% 
 
 
 
 Only common symptoms are noted above. The symptoms in order 
to frequency are epistaxis, nasal obstruction, nasal disturbances oral 
symptoms and cheek swelling. More than one symptoms were present in 
all cases. 
 
  
 
CLASSIFICATION AND STAGING 
 
TNM staging No. of cases 
T1 0 
T2 2 
T3 15 
T4 3 
N0 20 
N1 0 
M0 20 
 
  
 We classified these tumours along the UICC classification. 
Majority of the lesions were T3 lesions. None of the patients in our study 
had regional neck nodes and distal metastasis. 
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HISTOLOGICAL CLASSIFICATION 
 
Type No. of cases Percentage 
Squamous cell carcinoma 19 95% 
Adenoid cystic carcinoma 1 5% 
   
 Majority of cases were squamous cell carcinoma ( i.e.,) 95%. 
 
BRODER’S GRADING OF SQUAMOUS CELL CARCINOMA 
Type No. of cases Percentage 
Well differentiated 12 63.15% 
Moderately differentiated 4 21.05% 
Poorly differentiated 2 10.05% 
Undifferentiated 1 5.26% 
 
 Majority of the patients in our study had well differentiated 
squamous cell carcinoma. Only one patient had undifferentiated 
carcinoma. 
 Broder's Grading of Squamous Cell Carcinoma
63.15%
21.05%
10.05%
5.26%
Well differentiated Moderately differentiated
Poorly differentiated Undifferentiated
 
  
 
 
CT SCAN PNS 
 
 No. of cases Percentage 
CT PNS showing bony 
erosion 
18 90% 
 
 
 CT scan showed bony erosion in 18 patients. In 2 cases in which 
no erosion was seen, there was cloudiness and soft tissue shadow in the 
maxillary sinus. 
  
 SYMPTOMS AND SIGNS AND STAGE OF DISEASE 
 
Symptoms 
and signs T1 T2 T3 T4 Total 
Oral 0 2 8 3 13 
Nasal 0 2 10 6 18 
Orbital 0 0 7 2 9 
Facial 0 0 8 2 10 
Neurological 0 0 0 3 3 
 
  Of the 13 patients presenting with oral symptoms and signs, 8 
come under T3, 3 under T4 and 2 under T2. Eventhough oral involvement 
starts with T2, it is observed that most patients with oral symptoms come 
under T3 and next comes T4. 
 18 patients presented with nasal symptoms and signs. Out of them 
10 belong to T3, 6 to T4 and two in T2. 
 9 patients presented with orbital symptoms and signs. Out of them 
7 belong to T3 while 2 belong to T4. 
 10 patients presented with facial symptoms and signs. Out of them 
8 belong to T3 while 2 belong to T4. 
 Only 3 patients presented with neurological symptoms and signs 
and all the 3 belong to T4. 
   
 
CLINICAL STAGING AND PEROPERATIVE STAGING 
  
         Peroperative  
                          
Stage 
Clinical Stage  
T1 T2 T3 T4 Total 
T1 0 0 0 0 0 
T2 0 2 0 0 2 
T3 0 0 12 3 15 
T4 0 0 0 3 3 
Total 0 2 12 6 20 
 
 
 Two patients belonging to clinical T2 correlate well with 
peroperative T stage. Out of the 15 clinical T3 tumours, 12 belong to 
peroperative T3 and 3 belong to per operative T4. All the clinical T4 
belong to peroperative T4. 
  
RADIOLOGICAL STAGING AND  PER – OPERATIVE STAGING 
  
         Peroperative  
                          Stage 
Radiological  
Stage   
T1 T2 T3 T4 Total 
T1 0 0 0 0 0 
T2 0 2 0 0 2 
T3 0 0 8 0 8 
T4 0 0 4 6 10 
Total 0 2 12 6 20 
 
 
 Two patients belonging to radiological T2 correlated well with 
peroperative T stage. All the 8 radiological T3 belong to peroperative T3. 
Out of the 9 radiological T4 tumours, 3 belong to peroperative T3 and 6 
belong to peroperative T4. 
  
 
CLINICAL STAGING AND PROGNOSIS 
 
Clinical 
stage 
3 months 6 months 1 years 2 years 
T1 0 0 0 0 
T2 2/2 2/2 2/2 1/1 
T3 15/15 12/13 9/10 7/8 
T4 3/3 3/3 2/2 1/2 
No. of cases 
followed up 
20 18 14 11 
 
 The patients were followed upto a maximum of 2 years. All 
patients belonging to clinical T2 has 100% survival rate upto 2 years. In 
T3 clinical staging, 15 out of 15 survived. 3 months follow up, 12 out of 
13 survived 6 months follow up, 9 out of 10 survived 1 year follow up 
and 7 out of 8 survived in 2 years follow up. 
 
 In T4 clinical stage 3 out of 3 survived 3 months follow up, 3 out 
of 3 survived 6months, follow up 2 out of 2 survived 1 years follow up 
and 1 out of 2 survived for 2 years.   
         
DISCUSSION  
 Malignant tumours of the maxillary sinus forms less than 2% of 
ENT malignancy. 
AGE INCIDENCE 
Majority of the cases presented in the later decades of life (i.e) in 
the 5th and 6th decades (65%). This compares favourably with studies 
carried out by other authors. Gallengher and Boles in their study of 60 
cases carried out at Michigan Hospital, found an average age of 62.5 
years with maximum incidence in 6th decades.  
 
SEX INCIDENCE  
 In our study 20 patient, there were 14 males and 6 female. 70% of 
the patients were males, which correlates well with other studies.  
  
INCIDENCE OF VARIOUS SYMPTOMS 
 
  Malignant tumours of maxillary sinus presents with wide range of 
symptoms. The symptoms occur only when the tumour breaches the bony 
walls maxilla. Due to its peculiar anatomy it often mimics other common 
and benign conditions. Thus it is invariably diagnosed at an advanced 
 stage making treatment difficulty and ineffective. So an attempt was 
made to find out the common symptoms thereby we can have a high 
degree suspicion when patients presents with these symptoms and 
diagnose it at an earlier stage. 
 
 In this study, it was found that epistaxis was the commonest 
symptom, followed by nasal obstruction, dental and facial symptoms. 
Oral ulcer and facial pain were found to be rare in comparison to above 
symptoms. So when an elderly patient present with nasal obstruction and 
epistaxis, carcinoma maxillary sinus should be suspected. This may help 
in early diagnosis. 
 
TNM STAGING  
 
    TNM staging system is a useful parameter on which treatment protocol 
can be based. It also helps to compare the results and standardize disease 
states. In our study 15 out of 20 patients had T3 lesions (i.e.) 75%. The 
remaining were T2 and T4 (around 25%) with no T1 case. None of the 
patients in our study had regional lymphnodes (N0). 
 
 
 
 Other series show the following occurrence 
S. 
No. 
Series T1 T2 T3 T4 
1.  Gallengher & 
Boles 
1 12 32 11 
2.  Rehan 0 8 16 6 
3.  Lee & Ogura 5 11 18 13 
4.  Present Study 0 2 15 3 
 
HISTOPATHOLOGY 
 
 Histopathological diagnosis was done in all the cases which 
presented to us and malignancy was proven in all these cases (i.e.) 100%. 
Of these 19 patients (i.e.) 95% patients had squamous cell carcinoma. 
Only one patient had adenoid cystic carcinoma. 
 
 In patients with squamous cell carcinoma, Broder’s grading was 
used to grade the percentage of undifferentiated cells. About 63% of the 
cases belonged to well differentiated grade which was most common. 
 
 
 
 
 SYMPTOMS AND SIGNS AND STAGE OF THE DISEASE  
 
 Symptoms in malignant tumours of maxillary sinus depends on the 
direction of spread. A malignant tumour which spreads superiorly 
presents with orbital symptoms and the which spreads medially present 
with nasal symptoms.  
 
 Even though oral involvement starts with T2, it is observed that 
most patients with oral symptoms and signs come under T3 and next 
comes T4. It implies that involvement of hard palate and floor of 
maxillary need not always produce oral symptoms and when oral 
symptoms occur the lesion becomes more extensive. 
  
Nasal symptoms and signs are common presentation of malignant 
tumours of maxilla in our study. Even though involvement of middle 
meatus comes under T2, most of patients, when they present with nasal 
symptoms and signs, belong to T3 (or) more due to quick spread to 
anterior ethmoid cells and other structures. 
 
 Involvement orbit elevates the T status to T3. When the patients 
delays their visit to the surgeon, this may advance to T4. So patients with 
 orbital symptoms and signs has almost equal possibility that he belongs to 
T3 (or) T4. 
 
 Facial symptoms produce gross disfigurement and brings the 
patient to the surgeon at the beginning of symptom. Most of the patients 
with facial symptoms and signs belong to T3. 
 
 Patients who had Group V symptoms (or) neurological symptoms 
belonged to T4. So neurological symptoms and signs correlate well with                
T stage of disease. 
CLINICAL AND RADIOLOGICAL STAGING 
 
 Both clinical and radiological staging correlates well with 
peroperative staging in T1 and T2 tumour. 
 Some of the clinical T3 tumours belong to T4 peroperatively and 
all clinical T4 correlate well with peroperative staging. Thus clinical 
staging tends to understage for advanced tumour. 
 All the radiological T3 tumours come under peroperative T3. 
Whereas, some of the radiological T4 tumours belong to T3 
peroperatively. This is because a haziness in the posterior ethmoids and 
sphenoid in CT PNS cannot be easily differentiated from a tumour or 
 mucosal thickening. Hence radiological staging tend to overstage for 
advanced tumour. 
 This evaluation may help in predicting the approximate extent of 
disease per operatively. 
 
CLINICAL STAGING TO PREDICT PROGNOSIS 
  In our setup, we followed up 90% of patients at 6 months, 70% of 
patients of 1 year and 60% of patients at 2 year. 
 In our study, patients with T3 tumour had around 53% survival rate 
at 2 years. Rehan et al (2000) also reported a 50% survival rate at 2 years. 
 CONCLUSION 
 
 Malignant tumours of maxillary sinus present in a quite advanced 
stage, even though the duration symptoms may be less. The tumour is 
usually more extensive than the symptomatology and clinical 
examination suggests. The low success rate may be due to advanced 
tumour at the time of diagnosis. 
 Symptoms and signs have important role in detecting malignant 
tumours of maxillary sinus earlier and in improving the outcome of the 
treatment. 
 Nasal symptoms are the commonest symptom and majority of the 
patients presenting with nasal symptoms belong to T3 and above even at 
initial presentation. 
 Clinical staging tends to understage and radiological staging tends 
to over stage the tumour. 
 Complete surgical removal of tumour with postoperative radiation 
therapy remains the gold standard for resectable lesions. 
 Maintaining a high suspicion while treating patients with 
prolonged unexplained nasal problems could help in improving the 
success rate in malignant tumours of maxillary sinus. 
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 MASTER CHART 
 
T Stage S. 
No. 
Name Age / 
Sex 
Symptoms Signs Radiological 
Findings 
Per-operative 
Findings 
Histo-
pathological 
grading 
Cli  Radio 
logical 
Per 
Op. 
1.  Mr.Subramani 62/M Oral, 
Epistaxis 
Maxillary tooth 
loosening 
Involvement of antral 
mucosa and alveolus 
Involvement of 
antral mucosa and 
alveolus 
Squamous cell 
carcinoma, Well 
differentiated 
T2 T2 T2 
2.  Mr.Periannan 55/M Oral Palatal bulge Involvement of antral 
mucosa and alveolus 
Involvement of 
antral mucosa and 
alveolus 
Squamous cell 
carcinoma, 
Moderately 
differentiated 
T2 T2 T2 
3.  Mrs.Anjalatchi 58/F Oral, Nasal 
Obstruction, 
Epistaxis 
Ulcer over the 
hard palate and 
alveolar 
Involvement of antral 
mucosa and alveolus, 
middle meatus, AEC. 
Involvement of 
antral mucosa and 
alveolus, hard palate, 
middle meatus, AEC 
Squamous cell 
carcinoma, 
Moderately 
differentiated 
T3 T3 T3 
4.  Mrs.Meenakshi 33/F Oral, 
Epistaxis, 
Cheek 
swelling 
Maxillary tooth 
loosening, nasal 
mass, cheek 
anaesthesia  
Involvement of antral 
mucosa and alveolus, 
orbital floor middle 
meatus, AEC. 
Involvement of 
antral mucosa and 
alveolus, orbital 
floor middle meatus, 
AEC. Pterygoid 
muscle 
Squamous cell 
carcinoma, Well 
differentiated 
T3 T3 T3 
5.  Mrs.Malliga 50/F Oral, 
Epistaxis, 
Nasal 
Obstruction 
Hard palate 
erosion, trismus 
Involvement of antral 
mucosa and alveolus, 
pterygoid fossa 
Involvement of 
antral mucosa 
alveolus, hard palate 
pterygoid fossa 
ethroid sinus 
Squamous cell 
carcinoma, Well 
differentiated 
T3 T3 T3 
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6.  Mr.Loganathan  31/M Oral, 
Epistaxis 
Nasal Mass, 
proptosis 
Involvement of antral 
mucosa, alveolus, 
orbital floor, middle 
meatus, AEC, PEC, 
Sphenoid.  
Involvement of 
antral mucosa, 
alveolus, orbital 
floor, middle 
meatus, AEC 
Squamous cell 
carcinoma, Well 
differentiated 
T3 T4 T3 
7.  Mr. Shankar 38/M Nasal 
Obstruction, 
Epistaxis, 
cheek 
swelling 
Gingivo buccal 
sulcus 
obliteration, 
nasal mass, 
cheek 
anaesthesia  
Involvement of antral 
mucosa, alveolus, and 
sub cutaneous tissue 
of cheek 
Involvement of 
antral mucosa, 
alveolus, anterior 
ethmoid sinus 
Squamous cell 
carcinoma, Well 
differentiated 
T3 T3 T3 
8.  Mr.Krishnan 55/M Oral, 
Epistaxis, 
cheek 
swelling 
Obliteration of 
gingivobuccal 
sulcus mass in 
cheek 
anaesthesia 
Involvement of antral 
mucosa, orbital floor, 
middle meatus, AEC.  
Involvement of 
antral mucosa, 
orbital floor, middle 
metaus, AEC.  
Squamous cell 
carcinoma, Well 
differentiated 
T3 T3 T3 
9.  Mr.Krishnan 41/M Oral, 
Epistaxis, 
Cheek 
Swelling 
Hard palate 
erosion, cheek 
mass 
Involvement of antral 
mucosa, alveolus, 
hard palate, middle 
meatus, AEC, PEC, 
Sphenoid  
Involvement of 
antral mucosa, 
alveolus, hard palate, 
middle meatus, 
AEC,  Subcutaneous 
tissue of cheek  
Squamous cell 
carcinoma, Well 
differentiated 
T3 T4 T3 
10.  Mr.Duraisamy 43/M Oral, 
Epistaxis, 
Cheek 
swelling  
Palatal bulge, 
trimus, nasal 
mass, cheek 
anaesthesia 
Involvement of antral 
mucosa, alveolar, 
hard palate, middle 
meatus, AEC. 
Involvement of 
antral mucosa, 
alveolus, hard palate,  
middle meatus, AEC 
Squamous cell 
carcinoma, Well 
differentiated 
T3 T3 T3 
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11.  Mr.Rangasamy 65/M Nasal 
Obstruction, 
Cheek 
Swelling 
Hard palate, 
erosion, mass in 
cheek, cheek 
anaesthesia, 
nasal mass 
Involvement of antral 
mucosa, hard palate, 
orbital floor, AEC, 
PEC, middle meatus, 
pterygoid plate 
Involvement of 
antral mucosa, hard 
palate, orbital floor, 
AEC, middle 
meatus, pterygoid 
fossa 
Squamous cell 
carcinoma, Well 
differentiated 
T3 T4 T3 
12.  Mrs.Annama 60/F Nasal 
Obstruction, 
Watering  of 
eye 
Nasal mass Involvement of antral 
mucosa, middle 
meatus, AEC 
Involvement of 
antral mucosa, 
middle meatus, AEC  
Squamous cell 
carcinoma, Well 
differentiated 
T3 T3 T3 
13.  Mrs.Govindam
mmal  
60/F Oral, 
Epistaxis, 
Nasal 
Obstruction 
Nasal mass, hard 
palate bulge 
Involvement of 
central mucosa, 
alveolar middle 
meatus, AEC 
Involvement of 
antral mucosa, 
alveolar, middle 
meatus, AEC 
Squamous cell 
carcinoma, 
Moderately 
differentiated 
T3 T3 T3 
14.  Mr.Munusamy 45/M Oral, 
epistaxis, 
Nasal 
Obstruction 
Nasal Mass, 
Hard palate, 
Swelling 
Invovlment of antral 
mucosa, alveolar, 
orbital floor, middle 
meatus, AEC, PEC, 
sphenoid 
Invovlement of 
antral mucosa, 
alveolar, orbital 
floor, middle 
meatus, AEC. 
Squamous cell 
carcinoma, 
Moderately 
differentiated 
T3 T4 T3 
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15.  Mr. Chennan 62/M Nasal 
Obstruction, 
Epistaxis, 
Watering of 
eye 
Nasal mass, 
proptosis 
Involvement of antral 
mucosa, alveolus, 
orbital floor, lamina, 
papyracea, middle 
meatus, AEC, PEC, 
Sphenoid, pterygoid, 
plate, infratemporal 
fossa 
Involvement of 
antral mucosa, 
alveolus, orbital 
floor, lamina, 
papyracea, middle 
meatus, AEC, PEC, 
Sphenoid, pterygoid, 
plate, infratemporal 
fossa 
Squamous cell 
carcinoma, Well 
differentiated 
T3 T4 T4 
16.  Mr.Bala 
Subramanian 
57/M Nasal 
Obstruction, 
Epistaxis, 
Cheek 
Swelling 
Palatal bulge, 
maxillary tooth, 
loosening, 
trismus, EOM 
restriction, mass 
in cheek, 
involvement of 
maxillary nerve 
Involvement of antral 
mucosa, alveolus, 
hard palate, orbital, 
floor, lamina, 
papyracea, middle 
meatus, AEC, PEC, 
pterygoid, plate, 
infratemporal, fossa  
Involvement of 
antral mucosa, 
alveolar, hard palate, 
orbital, floor, 
lamina, papyracea, 
middle meatus, 
AEC, PEC, 
pterygoid, plate, 
infratemporal, fossa  
Squamous cell 
carcinoma, Well 
differentiated 
T3 T4 T4 
17.  Mr.Selvakum
ar 
52/M Nasal 
obstruction, 
Oral, cheek 
swelling 
Hard palate 
erosion, alveolar 
erosion, nasal 
mass, trismus, 
proptosis, cheek 
swelling, 
involvement 
maxillary nerve 
Involvement of antral 
mucosa, alveolus, 
hard palate, orbital 
floor, lamina 
papyraceae, middle 
meatus, AEC, PEC, 
sphenoid, pterygoid 
plate, infratemporal 
fossa     
Involvement of 
antral mucosa, 
alveolus, hard palate, 
orbital floor, lamina 
papyraceae, middle 
meatus, AEC, PEC, 
sphenoid, pterygoid 
plate, infratemporal 
fossa     
Adenoid cystic 
carcinoma 
T3 T4 T4 
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No. 
Name Age / 
Sex 
Symptoms Signs Radiological 
Findings 
Per-operative 
Findings 
Histo-
pathological 
grading 
Cli Radio 
logical 
Per 
Op. 
18.  Mr.Ramar 29/M Nasal 
Obstruction, 
Epistaxis, 
cheek 
swelling, 
Watering of 
eye 
Nasal Mass 
maxillary tooth 
loosening, cheek 
mass, cheek 
anaesthesia, 
proptosis 
Involvement of antral 
mucosa, alveolus, 
orbital floor, lamina 
papyraceae, middle 
meatus, AEC, PEC, 
pterygoid plate, 
infratemporal fossa  
Involvement of 
antral mucosa, 
alveolus, orbital 
floor, lamina 
papyraceae, middle 
meatus, AEC, PEC, 
sphenoid, pterygoid 
muscle, pterygoid 
plate infratemporal 
fossa  
Squamous cell 
carcinoma,            
Undifferentiated 
T4 T4 T4 
19.  Mrs.Kanchana 41/F Nasal 
Obstruction, 
Oral, Cheek 
Swelling 
Palatal bulge, 
obliteration of 
gingivo buccal 
sulcus, trismus, 
nasal mass, 
cheek mass, 
proptosis, cheek 
anaesthesia, 
nasopharyngeal 
extension  
Involvement of antral 
mucosa, alveolus, 
hard palate, orbital 
floor, middle meatus, 
AEC, PEC, sphenoid, 
nasopharynx. 
Involvement of 
antral mucosa, 
alveolus, hard palate, 
orbital floor, middle 
meatus, AEC, PEC, 
sphenoid, 
nasopharynx. 
Squamous cell 
carcinoma,            
Poorly 
differentiated 
T4 T4 T4 
20.  Mr.Annamalai 65/M Nasal 
Obstruction, 
Epistaxis, 
Orbital, 
Neurological 
Nasal mass 
proptosis, 
Nasopharynx 
extension  
Involvement of antral 
mucosa, orbital floor, 
lamina papyracea, 
middle meatus, AEC, 
PEC, Nasopharynx, 
Sphenoid 
Involvement of 
antral mucosa, 
orbital floor, lamina 
papyracea, middle 
meatus, AEC, PEC, 
Nasopharynx, 
Sphenoid, Orbital 
periosteum 
Squamous cell 
carcinoma,            
Moderate  
differentiated 
T4 T4 T4 
 
 KEY TO MASTER CHART  
 
 
1. Cli.  - Clinical 
 
2. Per Op - Peroperative 
 
3. AEC - Anterior ethmoidal cells 
 
4. PEC - Posterior ethmoidal cells 
 
5. OME - Otitis Media with Effusion 
 
6. EOM - Extra Ocular Movements 
 
   
 
